has the whole industrial chain of R&D, manufacturing, and commercialization. We committed to provide more effective and accessible therapy and innovative medicines to fulfill global medical needs. Since 2017, an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation was established.
Dr. Liu Datao, Co-founder and CEO of Mabwell, was Honored as “Sci-Tech Innovation Board Leaders，2022”
Dr. Liu Datao, CEO of Mabwell Bioscience, was invited to participate in the live interview of "International Biopharma Industry Week Shanghai 2022" by Yicai